Fulcrum Capital’s DexCom DXCM Stock Holding History

Fulcrum Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.91M	Sell	43,272 -1,468	-3%	-$97.8K	0.59%	39
2026 Q1	$2.81M	Buy	44,740 +3,654	+9%	+$254K	0.61%	37
2025 Q4	$2.73M	Buy	41,086 +1,267	+3%	+$81.9K	0.55%	39
2025 Q3	$2.68M	Buy	39,819 +1,938	+5%	+$153K	0.55%	38
2025 Q2	$3.31M	Buy	37,881 +3,809	+11%	+$299K	0.7%	37
2025 Q1	$2.33M	Buy	+34,072	New	+$2.78M	0.52%	38

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fulcrum Capital's DXCM Position: Q2 2026 in Review

Fulcrum Capital reduced its DexCom (DXCM) stake by 3.3% in Q2 2026, selling an estimated $97.8K and leaving 43,272 shares worth $2.91M. The position accounts for 0.59% of the portfolio, ranked #39.

Fulcrum Capital first reported a position in DXCM in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.31M in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Fulcrum Capital held 43,272 shares of DexCom worth $2.91M as of Q2 2026.
Fulcrum Capital sold 1,468 DexCom shares in Q2 2026, an estimated $97.8K.
DexCom made up 0.59% of Fulcrum Capital's portfolio in Q2 2026, its #39 holding.
Fulcrum Capital first reported a position in DexCom in Q1 2025 and has held it in 6 quarters since.
Fulcrum Capital's DexCom position peaked at $3.31M in Q2 2025.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Fulcrum Capital's 13F filing for Q2 2026, filed 21 Jul 2026.